Until share value is unlocked, Cantor’s Louise Chen finds it difficult to recommend TEVA shares.
New Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) CEO Kare Schultz held his first call today to dive into the fresh restructuring strategy to …
Should you pull the trigger on Teva? Guggenheim’s Rohit Vanjani is fine staying sidelined.
Will generic Viagra turn Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) shares to the upside? Today, the generic drug giant announced the exclusive launch of …
A Wall Street high-roller like Ken Griffin did not make it among the big leagues a.k.
Ken Griffin is a man known to be raring to take a risk when it is worthwhile, a daring and strategic mindset that …
After talking with Teva Pharmaceutical (NYSE:TEVA) management, Mizuho analyst Irina Rivkind Koffler is more positive on the rebounding Israeli pharma giant in the …
Mizuho’s Irina Rivkind Koffler may remain apprehensive on generics competition, but the analyst likes what she sees with new plans for corporate restructuring.
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has given investors news to stoke some enthusiasm after a long road of debt, exclusivity on multiple …
Teva has stirred up Street excitement with news of executive changes and an organizational overhaul.